Tag: residual solvents

How Stability Data Affects API Specifications and Release Limits The Impact of Stability Data on API Specifications and Release Testing In pharmaceutical development, Active Pharmaceutical Ingredients (APIs) are crucial components that dictate the efficacy and safety of finished products. Understanding…

API Specifications in Regulatory Submissions: What Must Be Justified? Understanding API Specifications and Release Testing in Pharmaceutical Regulatory Submissions In the pharmaceutical industry, the development and manufacturing of Active Pharmaceutical Ingredients (APIs) are critical steps that require rigorous scrutiny, especially…

Why API Release Testing Matters for Downstream Formulation and Manufacturing The Importance of API Release Testing for Effective Downstream Formulation and Manufacturing Active Pharmaceutical Ingredients (APIs) are the cornerstone of drug formulations, playing a critical role in determining the efficacy…

Compendial vs In-House API Specifications in Pharma: When and Why They Differ Understanding the Differences Between Compendial and In-House API Specifications in Pharma In the pharmaceutical industry, adherence to rigorous standards is paramount to ensure the safety, efficacy, and quality…

OOS Results in API Release Testing: Common Root Causes and CAPA Understanding OOS Results in API Release Testing: Root Causes and Corrective Actions In the pharmaceutical industry, API (Active Pharmaceutical Ingredient) specifications and release testing are critical components of ensuring…